Oncology
Division Reports
Our Research Annual Report features division summaries and significant publications from more than 50 research divisions and institutes.
View all Division ReportsOncology
Featured Research
Inhibiting MEK Protein Shrinks NF1 Plexiform Tumors After five other medications fail, selumetinib becomes first to demonstrate lasting improvement. In some ways, the impressive results from a clinical trial published in The New England Journal of Medicine mark the triumph of a scientific career.
Read Featured Research
Division Summary
| Research and Training Details | |
|---|---|
| Faculty | 26 |
| Joint Appointment Faculty | 3 |
| Research Fellows and Post Docs | 6 |
| Research Graduate Students | 4 |
| Total Annual Grant Award Dollars | $2,428,147 |
| Total Annual Industry Award Dollars | $851,654 |
| Clinical Activities and Training | |
|---|---|
| Staff Physicians | 8 |
| Clinical Fellows | 8 |
| Inpatient Encounters | 1,266 |
| Outpatient Encounters | 14,793 |
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
